Clinical Trial Update: An Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of CB-03-01 Cream in Subjects With Acne Vulgaris [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating CB-03-01 cream for acne vulgaris, focusing on adrenal suppression potential and pharmacokinetics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• CB-03-01 cream

Snippet

Sponsor: Intrepid Therapeutics, Inc. | Conditions: Acne Vulgaris | Phase 2 | Status: COMPLETED | Results posted: 2020-11-17